Segment Information

6 Months Ended

Jun. 30, 2012

Segment Reporting [Abstract]

Segment Information

(10) Segment Information

The Company has six reportable segments which include; Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation. Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended June 30,				Six months ended June 30,
Sale of Product	2012		2011		2012		2011
Radiochemical Products	$	405,118	$	475,901	$	787,033	$	917,201
Cobalt Products		484,098		821,409		833,430		1,234,244
Nuclear Medicine Standards		1,074,124		1,186,399		2,202,129		2,579,556
Radiological Services		40,593		57,635		65,883		134,250
Flourine Products		-		-		-		-
Transportation		39,016		73,400		103,817		162,808
Total Segments		2,042,949		2,614,744		3,992,292		5,028,059
Corporate revenue		-		-		-		-
Total Consolidated	$	2,042,949	$	2,614,744	$	3,992,292	$	5,028,059

	Three months ended June 30,				Six months ended June 30,
Depreciation and Amortization	2012		2011		2012		2011
Radiochemical Products	$	9,294	$	9,155	$	18,587	$	18,308
Cobalt Products		23,766		27,401		46,846		54,769
Nuclear Medicine Standards		6,585		3,090		10,720		5,954
Radiological Services		2,600		2,600		5,200		5,200
Flourine Products		35,845		48,483		103,303		88,045
Transportation		3,351		3,395		6,746		7,018
Total Segments		81,441		94,124		191,402		179,294
Corporate depreciation and amortization		10,800		17,039		12,189		33,932
Total Consolidated	$	92,241	$	111,163	$	203,591	$	213,226

	Three months ended June 30,				Six months ended June 30,
Segment Income (Loss)	2012		2011		2012		2011
Radiochemical Products	$	22,232	$	54,459	$	18,257	$	89,854
Cobalt Products		146,267		392,070		251,601		623,579
Nuclear Medicine Standards		157,943		195,051		321,844		399,964
Radiological Services		33,641		30,655		33,367		83,560
Flourine Products		(307,358)		(1,701,456)		(558,477)		(3,292,659)
Transportation		(22,939)		13,184		(24,702)		23,465
Total Segments		29,786		(1,016,037)		41,890		(2,072,237)
Corporate loss		(544,918)		(654,149)		(1,147,269)		(1,312,961)
Net Loss	$	(515,132)	$	(1,670,186)	$	(1,105,379)	$	(3,385,198)

	Three months ended June 30,				Six months ended June 30,
Expenditures for Segment Assets	2012		2011		2012		2011
Radiochemical Products	$	-	$	-	$	2,793	$	-
Cobalt Products		23,181		1,965		31,742		1,965
Nuclear Medicine Standards		823		44,759		823		83,065
Radiological Services		-		-		-		-
Flourine Products		455,639		19,865		1,131,756		37,161
Transportation		-		-		-		18,047
Total Segments		479,643		66,589		1,167,114		140,238
Corporate purchases		-		-		3,414		9,831
Total Consolidated	$	479,643	$	66,589	$	1,170,528	$	150,069

	June 30,		December 31,
Segment Assets	2012		2011
Radiochemical Products	$	209,283	$	196,065
Cobalt Products		1,751,816		1,586,748
Nuclear Medicine Standards		467,201		1,019,239
Radiological Services		8,698		19,646
Flourine Products		5,930,078		4,922,409
Transportation		32,866		39,112
Total Segments		8,399,942		7,783,219
Corporate assets		2,665,266		4,147,586
Total Consolidated	$	11,065,208	$	11,930,805